Trial Profile
DPP-4(Dipeptidyl peptidase-4) inhibitor Sitagliptin Phosphate Hydrate study to the inhibition of extension atherosclerosis.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2011
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 21 Jan 2011 New trial record